Table 4.
Histology | Age group (years) | 1-year survival (%) | 2-year survival (%) | 5-year survival (%) | 10-year survival (%) |
---|---|---|---|---|---|
Pilocytic astrocytoma | 0–19 | >98 | 98 | 97 | 95 |
20–44 | >95 | 95 | 90 | 85 | |
Diffuse astrocytoma | 0–19 | 92.5 | 87 | 82.5 | 80 |
20–44 | 90 | 85 | 65 | 45 | |
Oligodendroglioma | 0–19 | >95 | 95 | 92 | 90 |
20–44 | 98 | 95 | 85 | 65 | |
Oligoastrocytic tumors | 0–19 | >90 | 87 | 82 | 75 |
20–44 | >95 | 90 | 70 | 55 | |
Anaplastic oligodendroglioma | 0–19 | Information not available | |||
20–44 | 95 | 85 | 65 | 50 | |
Anaplastic astrocytoma | 0–19 | 65 | 45 | 30 | 25 |
20–44 | 85 | 70 | 50 | 35 | |
Glioblastoma | 0–19 | 55 | 30 | 18 | 12 |
20–44 | 65 | 35 | 18 | 10 |
Notes: Adapted from Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol. 2014;16(Suppl 4):iv1–iv63, by permission of Oxford Univeristy Press.1
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results.